Differences
This shows you the differences between two versions of the page.
| Both sides previous revision Previous revision Next revision | Previous revision | ||
| rop_screening_guidelines [2022/02/10 02:33] – [Timing of follow-up examinations] Scott Larson | rop_screening_guidelines [2025/09/29 19:04] (current) – Scott Larson | ||
|---|---|---|---|
| Line 1: | Line 1: | ||
| - | ====== ROP Screening Guidelines | + | ====== ROP Screening Guidelines- U Iowa ====== |
| ==== Any one of the following criteria qualifies the patient for ROP screening ==== | ==== Any one of the following criteria qualifies the patient for ROP screening ==== | ||
| - Infants with a birth weight of < 1500 grams | - Infants with a birth weight of < 1500 grams | ||
| Line 28: | Line 28: | ||
| * Type 1 or Threshold ROP | * Type 1 or Threshold ROP | ||
| * Zone 1 any stage with plus disease | * Zone 1 any stage with plus disease | ||
| - | * Stage 3 in Zone I, Stage 3 in Zone II | + | * Stage 3 in Zone I, Stage 3 in Zone II or III with plus |
| - | * III with plus | + | |
| * treatment recommended within 72 hours with follow up weekly thereafter until regression. | * treatment recommended within 72 hours with follow up weekly thereafter until regression. | ||
| - | * Regressing ROP and vascularized into Zone III- two to 8 weeks intervals until mature or meets other guidelines to stop screening (see below) | + | * Regressing ROP and vascularized into Zone III |
| + | * two to 8 weeks intervals until mature or meets other guidelines to stop screening (see below) | ||
| * The frequency of the follow-up depends upon the severity of the disease, zone of involvement, | * The frequency of the follow-up depends upon the severity of the disease, zone of involvement, | ||
| Line 49: | Line 49: | ||
| ==== Resources ==== | ==== Resources ==== | ||
| - | - {{ :: | + | - {{:: |
| - | {{tag>ROP}} | + | {{tag>rop}} |